Cost Effectiveness Analysis [ocac]
Percutaneous [spco]
Sclerotherapy [topp]
Venous [bpoc]
malformations [ftcn]
Purpose [ftcn]
To [qlco]
Assess [acty]
Cost Effectiveness [qnco]
Sclerotherapy [topp]
Venous malformation [anab]
Quality of life [idcn]
Materials [sbst]
Methods [inpr]
This [euka]
Study, Prospective [resa]
Patients [podg]
Symptomatic [ftcn]
Venous malformation [anab]
Sclerotherapy [topp]
EuroQOL [inpr]
Dimension [qnco]
Short Forms [inpr]
Survey, Health [resa]
To [qlco]
Measure [qnco]
Health [idcn]
Quality of life [idcn]
Questionnaires [inpr]
Collected [idcn]
months [tmco]
Sclerotherapy [topp]
Quality-Adjusted Life Years [tmco]
I- [inch]
Calculated [ftcn]
Using [ftcn]
EuroQOL [inpr]
Dimension [qnco]
Score [qnco]
Measure [qnco]
Health [idcn]
utility [orgt]
Medical [ftcn]
Costs [qnco]
Obtained [ftcn]
Hospital [hcro, mnob]
Accounting [ocac]
System [ftcn]
Costs [qnco]
Staff [prog]
Drugs [phsu]
Materials [sbst]
Angiographies [diap]
Equipment [mnob]
Calculated [ftcn]
Procedure [diap, topp]
Cost Effectiveness [qnco]
Analyzed [resa]
Using [ftcn]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
Medical [ftcn]
Cost [qnco]
Gain [qnco]
Quality-Adjusted Life Years [tmco]
Result [ftcn]
median [spco]
EuroQOL [inpr]
Dimension [qnco]
Scores [qnco]
Improved [qlco]
Range [qnco]
Range [qnco]
months [tmco]
P NOS [aapp, imft]
Range [qnco]
months [tmco]
P NOS [aapp, imft]
Gain [qnco]
Quality-Adjusted Life Years [tmco]
months [tmco]
Mean [qnco]
Medical [ftcn]
Cost [qnco]
SIC [clas]
Pain [sosy]
Group [idcn]
baseline [bodm]
Pain scale [diap]
Short Forms [inpr]
Score [qnco]
Show [inpr]
Improvement [cnce]
median [spco]
EuroQOL [inpr]
Dimension [qnco]
Score [qnco]
Range [qnco]
Range [qnco]
months [tmco]
P NOS [aapp, imft]
Range [qnco]
months [tmco]
P NOS [aapp, imft]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
months [tmco]
SIC [clas]
Overall [inpr]
Group [idcn]
Decreased [qnco]
SIC [clas]
Pain [sosy]
Group [idcn]
SIC [clas]
Threshold [qlco]
Health Benefit [qnco]
Japan [geoa]
Accounting [ocac]
Increase [ftcn]
Costs [qnco]
Conclusions [idcn]
Sclerotherapy [topp]
Cost Effectiveness [qnco]
For [qlco]
Improving [qlco]
Quality of life [idcn]
Symptomatic [ftcn]
Venous malformation [anab]
Patients [podg]
Moderate [qlco]
Severe pain [sosy]
